Lee et al., 2002 - Google Patents
Interactions of RXR with coactivators are differentially mediated by helix 11 of the receptor's ligand binding domainLee et al., 2002
- Document ID
- 16367031748709287714
- Author
- Lee W
- Noy N
- Publication year
- Publication venue
- Biochemistry
External Links
Snippet
RXR is a nuclear hormone receptor that is activated by the vitamin A metabolite 9-cis- retinoic acid. Previously, it was shown that, in the absence of a cognate ligand, RXR self- associates into tetramers, thereby silencing its own transcriptional activity. It was also shown …
- 230000003081 coactivator 0 title abstract description 164
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Natochin et al. | Inhibition of GDP/GTP exchange on Gα subunits by proteins containing G-protein regulatory motifs | |
Zhang et al. | ROR nuclear receptors: structures, related diseases, and drug discovery | |
Hadzopoulou-Cladaras et al. | Functional domains of the nuclear receptor hepatocyte nuclear factor 4 | |
Suino et al. | The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization | |
Stehlin-Gaon et al. | All-trans retinoic acid is a ligand for the orphan nuclear receptor RORβ | |
Ren et al. | Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors | |
Kojetin et al. | Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery | |
Bain et al. | Nuclear receptor structure: implications for function | |
Kraichely et al. | Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-α and estrogen receptor-β: correlations with biological character and distinct differences among SRC coactivator family members | |
Wärnmark et al. | Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation | |
Zhang et al. | A novel role for helix 12 of retinoid X receptor in regulating repression | |
Budhu et al. | Localization of the RAR interaction domain of cellular retinoic acid binding protein-II | |
Kersten et al. | Retinoid X receptor alpha forms tetramers in solution. | |
Teichert et al. | Quantification of the Vitamin D Receptor− Coregulator Interaction | |
Sumanasekera et al. | Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-α (PPARα) and PPARβ activity | |
Castro et al. | Activity of the Nurr1 carboxyl-terminal domain depends on cell type and integrity of the activation function 2 | |
Lee et al. | Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties | |
Javitch et al. | The fourth transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle | |
Dong et al. | Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties | |
Tamrazi et al. | Molecular sensors of estrogen receptor conformations and dynamics | |
Kersten et al. | Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently | |
Stanley et al. | Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity | |
Kersten et al. | Auto-silencing by the retinoid X receptor | |
Kersten et al. | The tetramerization region of the retinoid X receptor is important for transcriptional activation by the receptor | |
Jeyakumar et al. | Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor |